“…In contrast to T47D, which has been genotyped to the well-differentiated 'luminal' phenotype of breast cancer, MDA-MB231 cells lack expression of E-cadherin and express matrix metalloproteinases, which are properties associated with a more aggressive tumorigenic phenotype, consistent with its 'basaloid' phenotype (Nawrocki et al, 2001;Gordon et al, 2003). In addition, MDA-MB231 cells have a significantly higher in vitro invasive index (Nawrocki et al, 2001;Gordon et al, 2003), are metastatic in nude mice (Inoue et al, 1993;Yoneda et al, 1997;Salcedo et al, 2000;Salcedo et al, 2002) and may therefore possess additional mutations that can circumvent Nek3 regulation. Although Western-blot analysis of equal amounts of protein in both cell lines showed no remarkable differences in basal Nek3 expression (Figure 3a), differences in PRL-mediated kinase activity and consequently phosphorylation of other proteins linked to cancer motility such as Vav2, PI3K, MAPK and paxillin may be significant.…”